vimarsana.com
Home
Live Updates
Metformin use linked to reduced risk of myeloproliferative n
Metformin use linked to reduced risk of myeloproliferative n
Metformin use linked to reduced risk of myeloproliferative neoplasms
People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published in Blood Advances.
Related Keywords
Denmark ,
Stidsholt ,
Nordjylland ,
United States ,
Aalborg ,
American ,
Danish ,
Daniel Tuyet Kristensen ,
Aalborg University Hospital ,
Aarhus University Hospital ,
American Society Of Hematology ,
Stidsholt Roug ,